Curus Medical – a biotechnology and companion cannabinoid healthcare company

Curus Medical and its partners have instigated pioneering research studies in a number of unmet medical conditions including phytocannabinoid companion compounds. Curus has widened the focus to encompass some potentially ground breaking therapeutics.

Working with pioneers in their respective disease sectors, Curus brings significant commercial, clinical study and funding experience to assist eminent researchers to achieve therapeutic goals.


Curus has partnerships with a number of research institutions as well as suppliers.

Derived from “Cure Us”, Curus Medical will instigate and invest in select research studies that provide investors with liquidity events with both near term and long term achievable milestones.

Additionally, Curus has a developed a select portfolio of healthcare products ripe for commercialisation.